A critical advance in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in many forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research